1. Home
  2. ABVX vs TPG Comparison

ABVX vs TPG Comparison

Compare ABVX & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$114.15

Market Cap

9.0B

Sector

N/A

ML Signal

HOLD

Logo TPG Inc.

TPG

TPG Inc.

HOLD

Current Price

$66.64

Market Cap

8.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABVX
TPG
Founded
2013
1992
Country
France
United States
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.9B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
ABVX
TPG
Price
$114.15
$66.64
Analyst Decision
Strong Buy
Buy
Analyst Count
12
12
Target Price
$118.33
$66.45
AVG Volume (30 Days)
1.9M
1.5M
Earning Date
08-11-2025
02-10-2026
Dividend Yield
N/A
2.64%
EPS Growth
N/A
N/A
EPS
N/A
0.10
Revenue
$6,231,374.00
$4,255,344,000.00
Revenue This Year
$6.80
N/A
Revenue Next Year
N/A
$31.12
P/E Ratio
N/A
$676.74
Revenue Growth
N/A
24.91
52 Week Low
$4.77
$37.52
52 Week High
$148.83
$70.38

Technical Indicators

Market Signals
Indicator
ABVX
TPG
Relative Strength Index (RSI) 43.25 57.58
Support Level $116.20 $63.79
Resistance Level $129.56 $70.38
Average True Range (ATR) 7.87 1.63
MACD -2.47 -0.11
Stochastic Oscillator 15.05 44.16

Price Performance

Historical Comparison
ABVX
TPG

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About TPG TPG Inc.

TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.

Share on Social Networks: